Research Article 
Drugs in development for management of lipoprotein disorders
W. Virgil Brown, Harold Bays, Michael Davidson and Anne Goldberg
Journal of Clinical Lipidology, 2011, 5(2), 66-75. DOI: 10.1016/j.jacl.2011.01.004
Abstract
Not available
ASCI-ID: 2746-189
Similar Articles
Effects of ABT-335 in Combination with Rosuvastatin on Low-Density Lipoprotein Particle Size in Patients with Mixed Dyslipidemia
Journal of Clinical Lipidology, 2008, 2(3), 219-220. DOI: 10.1016/j.jacl.2008.04.032
Effects of Prescription Omega-3-Acid Ethyl Esters Plus Simvastatin on Lipids and Lipoprotein Particles in Mixed DyslipidemiaJournal of Clinical Lipidology, 2008, 2(3), 222-223. DOI: 10.1016/j.jacl.2008.04.038
Cholesterol, lipoproteins, and cognitive impairmentJournal of Clinical Lipidology, 2009, 3(6), 368-371. DOI: 10.1016/j.jacl.2009.10.002
Point: Low-density lipoprotein cholesterol goals in patients with diabetes are not adequately based on evidenceJournal of Clinical Lipidology, 2010, 4(1), 69-71. DOI: 10.1016/j.jacl.2009.12.003
Extremely elevated lipoprotein(a), combined hyperlipidemia, and premature atherosclerosis in a Chinese familyJournal of Clinical Lipidology, 2010, 4(6), 543-547. DOI: 10.1016/j.jacl.2010.09.002
Changes in Lipoprotein-associated Phospholipase A2 with Ezetimibe/Simvastatin Co-administered with ER Niacin in Type II HyperlipidemiaJournal of Clinical Lipidology, 2012, 6(3), 253-254. DOI: 10.1016/j.jacl.2012.04.011
Changes in Lipoprotein Particle Number with Ezetimibe/Simvastatin Co-administered with Extended-Release Niacin in Patients with Type II HyperlipidemiaJournal of Clinical Lipidology, 2012, 6(3), 254-255. DOI: 10.1016/j.jacl.2012.04.012
Body fat distribution, lipoprotein metabolism, and insulin resistance: A lifetime of research on the pathophysiology of the human metabolic syndromeJournal of Clinical Lipidology, 2012, 6(6), 601-603. DOI: 10.1016/j.jacl.2012.08.006
Relationships between alcohol intake and atherogenic indices in womenJournal of Clinical Lipidology, 2013, 7(5), 454-462. DOI: 10.1016/j.jacl.2013.03.009
Managing to low-density lipoprotein particles compared with low-density lipoprotein cholesterol: A cost-effectiveness analysisJournal of Clinical Lipidology, 2013, 7(6), 642-652. DOI: 10.1016/j.jacl.2013.06.004
JCL Roundtable: Health information technology in the management of lipoprotein disordersJournal of Clinical Lipidology, 2014, 8(2), 137-147. DOI: 10.1016/j.jacl.2013.12.009